By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Voyager Pharmaceutical Corporation 

8540 Colonnade Center Drive
Suite 501
Raleigh  North Carolina  27615  U.S.A.
Phone: 919-846-4880 Fax: 919-846-4881



Start Up

Company News
Sanofi (SAN.PA)'s Genzyme (GENZ) Jumps Into Neuro Gene Therapies With $845 Million R&D Voyager Pharmaceutical Pact 2/11/2015 5:47:02 AM
Voyager Pharmaceutical Corporation Taps Ex-Eli Lilly and Company (LLY) Exec For CEO Post 9/3/2014 6:06:44 AM
REGENX Biosciences, LLC And Voyager Pharmaceutical Corporation Announce License Agreement 6/2/2014 10:03:33 AM
DURECT Corporation (DRRX) Provides an Update to the Memryte(TM) Program Under Development by Voyager Pharmaceutical Corporation 5/18/2007 12:26:32 PM
DURECT Corporation (DRRX) Amends Agreement With Voyager Pharmaceutical Corporation Governing Memryte(TM) 1/24/2007 12:53:03 PM
DURECT Corporation (DRRX) Provides An Update To The Memryte(TM) Program Under Development By Voyager Pharmaceutical Corporation; Voyager Ends Trial Of Drug 10/19/2006 9:35:01 AM
Voyager Pharmaceutical Corporation Release: Novel Approach May Offer New Hope To Women With Alzheimer's Disease, Study Shows 7/17/2006 2:38:11 PM
Voyager Pharmaceutical Corporation Announces The Formation Of Its Medical And Scientific Advisory Board 7/13/2006 12:58:54 PM
Voyager Pharmaceutical Corporation Release: Leuprolide Acetate Stabilizes Cognitive And Functional Decline In Women With Alzheimer's Disease, Study Shows 5/16/2006 1:25:56 PM
Voyager Pharmaceutical Corporation Completes Second Phase II Clinical Study For Alzheimer's Disease 5/3/2006 1:32:19 PM